Harmonic Bionics Announces In-Person Demonstrations of New Upper Extremity Exoskeleton at Rehab Facilities Beginning Later This Summer

Harmonic Bionics, Inc. announced today that they have begun scheduling appointments for in-person demonstrations of Harmony SHR™, a new bilateral, upper extremity exoskeleton. Starting later this summer, the Harmonic Bionics team will be traveling around the country to showcase the robotic system to the rehabilitation community at different hospitals, clinics, and inpatient rehabilitation facilities that have expressed interest in the technology.

In May, the company announced the close of a Series A round of funding and began one of the first clinical studies with Harmony SHR to test safety and usability at a major hospital in Austin. The team was also able to perform a few of the first hands-on demonstrations at facilities in their home state of Texas.

“We have performed close to 150 virtual demonstrations over the past year and there is a lot of excitement around Harmony SHR, so we are ready to provide caregivers hands-on demonstrations of the system,” said Harmonic Bionics CEO Christopher Prentice. “These first few demonstrations have confirmed that Harmony SHR’s unique design can augment a therapist’s ability to provide upper body assessment and rehabilitation for patients with movement disorders.”

Request an in-person demo of Harmony SHR. Virtual demonstrations will continue to be held through August.

About Harmonic Bionics, Inc.

Harmonic Bionics, the robotics company for augmenting human movement, aims to empower patients and their care providers by designing intelligent technology that facilitates data-driven treatment for neurological and musculoskeletal movement impairments. Our flagship product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to provide unique value in three areas of practice: neuroscience and movement science research, movement disorder assessment, and rehabilitation. We intend to optimize upper extremity therapy with Harmony SHR by enabling early intervention, increasing functional repetition, and employing patient-specific intent-based therapy through novel exercises.